Development of a COVID-19 Vaccine Hesitancy Single Session Group Intervention for US Veterans

Article Sidebar

PDF Download
Published Dec 21, 2022
DOI: https://doi.org/10.18103/mra.v10i12.3216

Downloads

Download data is not yet available.

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Author Registration

Join the Society

The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.

Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.

Membership

Main Article Content

Emily L Mitchell Sarah R. Sullivan
James J Peters VAMC
Kyra K Hamerling-Potts Matthew F Dobbs Joseph C Geraci Marianne Goodman

Abstract

Background: COVID-19 vaccine hesitancy remains problematic and is particularly prevalent in minority and underserved communities.


Aim and Scope: The development and initial efficacy of a single-session Vaccine Hesitancy-focused Telehealth Group at a Veterans hospital in the Bronx, NY are described. This single-session telehealth group integrated motivational interviewing, psychoeducation, and a “vaccine positive” peer with the goal of addressing COVID-19 vaccine hesitancy and improving vaccination rates.


Methods: This project was approved by the quality assurance and improvement team at the James J. Peters VA Medical Center in the Bronx, NY. From the vaccine-hesitant Veteran referrals received from providers, eight vaccine hesitancy groups, averaging 3.5 participants  per session, were conducted. Thirty Veterans total participated in the telehealth group.


Results: Two-thirds of the participants have received the COVID-19 vaccine, with the vast majority of participants receiving the vaccine after the group. About half of the participants (n=14) were more willing to get the vaccine following the intervention and none experienced an increase in hesitancy.


Conclusions: Preliminary results suggest this may be one intervention to increase vaccine acceptability and COVID-19 vaccination rates. Program strengths, limitations, and suggestions are discussed.

Keywords: vaccine hesitancy, COVID-19, SARS-CoV-2, health behaviors, intervention

Article Details

How to Cite
MITCHELL, Emily L et al. Development of a COVID-19 Vaccine Hesitancy Single Session Group Intervention for US Veterans. Medical Research Archives, [S.l.], v. 10, n. 12, dec. 2022. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/3216>. Date accessed: 27 apr. 2024. doi: https://doi.org/10.18103/mra.v10i12.3216.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 10 No 12 (2022): December issue, Vol.10 Issue 12
Section
Research Articles

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

References

1. HHS Fact Sheet: Explaining Operation Warp Speed. Available at: https://www.hhs.gov/coronavirus/explainingoperation-warp-speed/index.html. Accessed on May 13 2021.
2. Khubchandani, J., Sharma, S., Price, J. H., Wiblishauser, M. J., Sharma, M., & Webb, F. J. (2021). COVID-19 vaccination hesitancy in the United States: a rapid national assessment. Journal of Community Health, 46(2), 270-277. https://doi.org/10.1007/s10900-020-00958-x
3. Kricorian, K., Civen, R., & Equils, O. (2022). COVID-19 vaccine hesitancy: Misinformation and perceptions of vaccine safety. Human Vaccines & Immunotherapeutics, 18(1), 1950504. https://doi.org/10.1080/21645515.2021.1950504
4. Coustasse, A., Kimble, C., & Maxik, K. (2021). COVID-19 and vaccine hesitancy: A challenge the United States must overcome. The Journal of Ambulatory Care Management, 44(1), 71-75. https://doi.org/10.1097/JAC.0000000000000360
5. Machingaidze, S. & Wiysonge, C. S. (2021). Understanding COVID-19 vaccine hesitancy. Nature Medicine, 27, 1338–1339. https://doi.org/10.1038/s41591-021-01459-7
6. Puri, N., Coomes, E. A., Haghbayan, H., & Gunaratne, K. (2020). Social media and vaccine hesitancy: New updates for the era of COVID-19 and globalized infectious diseases. Human Vaccines & Immunotherapeutics, 16(11), 2586-2593. https://doi.org/10.1080/21645515.2020.1780846
7. Garett, R., & Young, S. D. (2021). Online misinformation and vaccine hesitancy. Translational Behavioral Medicine, ibab128. Advance online publication. https://doi.org/10.1093/tbm/ibab128
8. Paul, E., Steptoe, A., & Fancourt, D. (2021). Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. The Lancet Regional Health-Europe, 1, 100012. https://doi.org/10.1016/j.lanepe.2020.100012
9. Kreps, S. E., & Kriner, D. L. (2021). Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: Evidence from a conjoint experiment. Vaccine. https://doi.org/10.1016/j.vaccine.2021.04.044
10. Kricorian, K., & Turner, K. (2021). COVID-19 vaccine acceptance and beliefs among Black and Hispanic Americans. PloS one, 16(8), e0256122. https://doi.org/10.1371/journal.pone.0256122
11. Ross, J., Diaz, C. M., & Starrels, J. L. (2020). The disproportionate burden of COVID-19 for immigrants in the Bronx, New York. JAMA Internal Medicine, 180(8), 1043-1044. https://doi.org/10.1001/jamainternmed.2020.2131
12. Dennis, C. L. (2003). Peer support within a health care context: A concept analysis. International Journal of Nursing Studies, 40(3), 321-332. https://doi.org/10.1016/S0020-7489(02)00092-5
13. Hu, J., Wu, Y., Ji, F., Fang, X., & Chen, F. (2020). Peer support as an ideal solution for racial/ethnic disparities in colorectal cancer screening: Evidence from a systematic review and meta-analysis. Diseases of the Colon & Rectum, 63(6), 850-858. https://doi.org/10.1097/DCR.0000000000001611
14. Ramchand, R., Ahluwalia, S. C., Xenakis, L., Apaydin, E., Raaen, L., & Grimm, G. (2017). A systematic review of peer-supported interventions for health promotion and disease prevention. Preventive Medicine, 101, 156-170. https://doi.org/10.1016/j.ypmed.2017.06.008
15. Matthias, M. S., McGuire, A. B., Kukla, M., Daggy, J., Myers, L. J., & Bair, M. J. (2015). A brief peer support intervention for veterans with chronic musculoskeletal pain: a pilot study of feasibility and effectiveness. Pain Medicine, 16(1), 81-87. https://doi.org/10.1111/pme.12571
16. Executive Order (2012). Exec. Order No. 13625, 3 C.F.R. 302.
17. Cook, J. A. (2011). Peer-delivered wellness recovery services: From evidence to widespread implementation Editorial Psychiatric. Rehabilitation Journal, 35(2), 87-89. https://doi.org/10.2975/35.2.2011.87.89
18. Solomon, P. (2004). Peer support/peer provided services underlying processes, benefits, and critical ingredients. Psychiatric Rehabilitation Journal, 27(4), 392. https://doi.org/10.2975/27.2004.392.401
19. Akel, K. B., Masters, N. B., Shih, S. F., Lu, Y., & Wagner, A. L. (2021). Modification of a vaccine hesitancy scale for use in adult vaccinations in the United States and China. Human Vaccines & Immunotherapeutics, 1-8. https://doi.org/10.1080/21645515.2021.1884476
20. Strully, K. W., Harrison, T. M., Pardo, T. A., & Carleo-Evangelist, J. (2021). Strategies to address COVID-19 vaccine hesitancy and mitigate health disparities in minority populations. Frontiers in Public Health, 9, 384. https://doi.org/10.3389/fpubh.2021.645268
21. Batra, K., Sharma, M., Dai, C. L., & Khubchandani, J. (2022). COVID-19 booster vaccination hesitancy in the United States: A multi-theory-model (MTM)-based national assessment. Vaccines, 10(5), 758. https://doi.org/10.3390/vaccines10050758